Reuters logo
BRIEF-Inovio's HIV vaccine produces nearly 100 pct immune response rates in clinical study
May 24, 2017 / 12:18 PM / 6 months ago

BRIEF-Inovio's HIV vaccine produces nearly 100 pct immune response rates in clinical study

May 24 (Reuters) - Inovio Pharmaceuticals Inc

* Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

* Inovio Pharmaceuticals Inc - amongst evaluated participants receiving PENNVAX-GP and IL-12 via im vaccination, 27 of 27 demonstrated a cellular response Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below